| Original language | English (US) |
|---|---|
| Pages (from-to) | 99-100 |
| Number of pages | 2 |
| Journal | International Journal of Advances in Rheumatology |
| Volume | 9 |
| Issue number | 3 |
| State | Published - 2011 |
ASJC Scopus subject areas
- Rheumatology
Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: A randomized, double-blind trial. Commentary
Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops
*Corresponding author for this work
Research output: Contribution to journal › Comment/debate › peer-review